BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee IK, Kim G, Kim DH, Kim BB. PEG-BHD1028 Peptide Regulates Insulin Resistance and Fatty Acid β-Oxidation, and Mitochondrial Biogenesis by Binding to Two Heterogeneous Binding Sites of Adiponectin Receptors, AdipoR1 and AdipoR2. Int J Mol Sci 2021;22:E884. [PMID: 33477324 DOI: 10.3390/ijms22020884] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Lee IK, Yoon KC, Kang SS, Seon SK, Lee K, Kim BB. Enhanced Immunomodulation, Anti-Apoptosis, and Improved Tear Dynamics of (PEG)-BHD1028, a Novel Adiponectin Receptor Agonist Peptide, for Treating Dry Eye Disease. Pharmaceutics 2022;15:78. [PMID: 36678707 DOI: 10.3390/pharmaceutics15010078] [Reference Citation Analysis]
2 Zhang S, Wu X, Wang J, Shi Y, Hu Q, Cui W, Bai H, Zhou J, Du Y, Han L, Li L, Feng D, Ge S, Qu Y. Adiponectin/AdiopR1 signaling prevents mitochondrial dysfunction and oxidative injury after traumatic brain injury in a SIRT3 dependent manner. Redox Biol 2022;54:102390. [PMID: 35793583 DOI: 10.1016/j.redox.2022.102390] [Reference Citation Analysis]
3 Martínez-Villaluenga C, Hernández-Ledesma B. Peptides for Health Benefits 2020. Int J Mol Sci 2022;23:6699. [PMID: 35743143 DOI: 10.3390/ijms23126699] [Reference Citation Analysis]